Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP866988.RABZB7QoJNtJbvi79BZy2tvWSK3RN8gYigq4FuFDNgYPc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP866988.RABZB7QoJNtJbvi79BZy2tvWSK3RN8gYigq4FuFDNgYPc130_assertion type Assertion NP866988.RABZB7QoJNtJbvi79BZy2tvWSK3RN8gYigq4FuFDNgYPc130_head.
- NP866988.RABZB7QoJNtJbvi79BZy2tvWSK3RN8gYigq4FuFDNgYPc130_assertion wasGeneratedBy ECO_0000203 NP866988.RABZB7QoJNtJbvi79BZy2tvWSK3RN8gYigq4FuFDNgYPc130_provenance.
- NP866988.RABZB7QoJNtJbvi79BZy2tvWSK3RN8gYigq4FuFDNgYPc130_assertion wasDerivedFrom befree-2016 NP866988.RABZB7QoJNtJbvi79BZy2tvWSK3RN8gYigq4FuFDNgYPc130_provenance.
- NP866988.RABZB7QoJNtJbvi79BZy2tvWSK3RN8gYigq4FuFDNgYPc130_assertion SIO_000772 21255398 NP866988.RABZB7QoJNtJbvi79BZy2tvWSK3RN8gYigq4FuFDNgYPc130_provenance.
- NP866988.RABZB7QoJNtJbvi79BZy2tvWSK3RN8gYigq4FuFDNgYPc130_assertion evidence source_evidence_literature NP866988.RABZB7QoJNtJbvi79BZy2tvWSK3RN8gYigq4FuFDNgYPc130_provenance.
- NP866988.RABZB7QoJNtJbvi79BZy2tvWSK3RN8gYigq4FuFDNgYPc130_assertion description "[RAD21 expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866988.RABZB7QoJNtJbvi79BZy2tvWSK3RN8gYigq4FuFDNgYPc130_provenance.